Novo Holdings A/S 13D and 13G filings for Bolt Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-04 4:20 pm Sale |
2022-12-29 | 13D | Bolt Biotherapeutics, Inc. BOLT |
Novo Holdings A/S | 0 0.000% |
-2,534,465 (Position Closed) |
Filing |
| 2022-12-28 2:51 pm Sale |
2022-12-21 | 13D | Bolt Biotherapeutics, Inc. BOLT |
Novo Holdings A/S | 2,534,465 6.700% |
-1,169,526 (-31.57%) |
Filing |
| 2022-09-30 4:48 pm Unchanged |
2022-09-27 | 13D | Bolt Biotherapeutics, Inc. BOLT |
Novo Holdings A/S | 3,703,991 9.800% |
0 (Unchanged) |
Filing |
| 2022-07-15 4:01 pm Sale |
2022-07-13 | 13D | Bolt Biotherapeutics, Inc. BOLT |
Novo Holdings A/S | 3,703,991 9.800% |
-800,000 (-17.76%) |
Filing |
| 2021-11-22 4:03 pm Unchanged |
2021-11-15 | 13D | Bolt Biotherapeutics, Inc. BOLT |
Novo Holdings A/S | 4,503,991 12.000% |
0 (Unchanged) |
Filing |
| 2021-02-11 4:36 pm Purchase |
2021-02-04 | 13D | Bolt Biotherapeutics, Inc. BOLT |
Novo Holdings A/S | 4,503,991 13.000% |
4,503,991 (New Position) |
Filing |